Skip to main content
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.890
+0.120 (2.52%)
At close: Mar 6, 2026, 4:00 PM EST
4.970
+0.080 (1.64%)
After-hours: Mar 6, 2026, 7:55 PM EST

Opus Genetics Revenue

Opus Genetics had revenue of $3.08M in the quarter ending September 30, 2025, a decrease of -20.38%. This brings the company's revenue in the last twelve months to $14.63M, up 74.60% year-over-year. In the year 2024, Opus Genetics had annual revenue of $10.99M, down -42.30%.

Revenue (ttm)
$14.63M
Revenue Growth
+74.60%
P/S Ratio
23.05
Revenue / Employee
$812,944
Employees
18
Market Cap
337.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
XOMA Royalty 47.11M
C4 Therapeutics 35.95M
X4 Pharmaceuticals 33.98M
Foghorn Therapeutics 24.52M
Shattuck Labs 1.00M
Adlai Nortye -1.35M
Revenue Rankings

IRD News

More News